Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M1,247Revenue $M113Net Margin (%)--Altman Z-Score--
Enterprise Value $M1,247EPS $-0.3Operating Margin %--Piotroski F-Score--
P/E(ttm)--Beneish M-Score--Pre-tax Margin (%)--Higher ROA y-yN
Price/Book--10-y EBITDA Growth Rate %--Quick Ratio--Cash flow > EarningsN
Price/Sales--5-y EBITDA Growth Rate %--Current Ratio--Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)--Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)--Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M86.1ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with CADX

Number of guru portfolios checked: 68.
No Entry found in the selected group of Gurus. You can

CADX is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


CADX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
LARUE WILLIAM RSVP, CFO, Treas, Asst Sec 2013-12-17Sell8,500$9.1253.29 view
AKER HAZEL MSVP, GC & Secretary 2013-12-16Sell13,014$8.7659.59 view
Byrd Scott A.SVP, Chief Commercial Officer 2013-12-02Sell7,812$9.1652.62 view
LARUE WILLIAM RSVP, CFO, Treas, Asst Sec 2013-11-18Sell36,000$7.391.51 view
AKER HAZEL MSVP, GC & Secretary 2013-11-15Sell52,056$7.4188.66 view
Byrd Scott A.SVP, Chief Commercial Officer 2013-11-15Sell10,416$874.75 view
Lloyd-Smith MalcolmSVP, Reg Affairs, Qual & Clin 2013-07-22Sell14,000$7.8578.09 view
AKER HAZEL MSVP, GC & Secretary 2013-07-22Sell6,507$7.8179 view
LARUE WILLIAM RSVP, CFO, Treas, Asst Sec 2013-07-17Sell9,000$7.2692.56 view
AKER HAZEL MSVP, GC & Secretary 2013-07-15Sell6,508$7.3490.46 view

Quarterly/Annual Reports about CADX:

    News about CADX:

    Articles On GuruFocus.com
    Can Malllinckrodt Keep on Crushing Expectations? Mar 19 2014 
    Cadence Pharmaceuticals Inc. Reports Operating Results (10-Q) Nov 05 2010 
    Cadence Pharmaceuticals Inc. (CADX) President, CEO Theodore R Schroeder sells 50,000 Shares Oct 04 2010 
    Cadence Pharmaceuticals Inc. Reports Operating Results (10-Q) Aug 06 2010 
    Cadence Pharmaceuticals Inc. (CADX) President, CEO Theodore R Schroeder sells 50,000 Shares Jul 01 2010 
    Cadence Pharmaceuticals Inc. (CADX) President, CEO Theodore R Schroeder sells 50,000 Shares Apr 01 2010 
    Cadence Pharmaceuticals Inc. (CADX) President, CEO Theodore R Schroeder sells 30,000 Shares Jan 04 2010 
    Cadence Pharmaceuticals Inc. Reports Operating Results (10-Q) Nov 05 2009 
    Cadence Pharmaceuticals Inc. (CADX) President, CEO Theodore R Schroeder sells 20,000 Shares Oct 19 2009 
    Cadence Pharmaceuticals Inc. Reports Operating Results (10-Q) Aug 06 2009 

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK